Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nupur Greene

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Managed Care & Specialty Pharmacy|May 13, 2025
Associations between chronic active lesions and clinical outcomes in multiple sclerosis: A systematic literature reviewFrancesca Bagnato, Margaret Mordin, Nupur Greene, et al.
Journal of Comparative Effectiveness Research|November 28, 2022
Health economic outcomes of switching to alemtuzumab from other disease-modifying therapies in people with multiple sclerosis in the USALita Araujo, Srikanth Kyatham, Kristen G Bzdek, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 29, 2022
Medication Adherence and Healthcare Utilization in Relapsing-Remitting Multiple Sclerosis Patients Using TeriflunomideNupur Greene, Keiko Higuchi, Katalin Bognar, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 26, 2023
Assessing the Health Economic Outcomes from Commercially Insured Relapsing Multiple Sclerosis Patients Who Switched from Other Disease-Modifying Therapies to Teriflunomide, in the United StatesLita Araujo, Srikanth Kyatham, Kristen G Bzdek, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 21, 2021
Influence of Comorbidities on Healthcare Expenditures and Perceived Physical and Mental Health Status Among Adults with Multiple Sclerosis: A Propensity Score-Matched US National-Level StudySandipan Bhattacharjee, Zufan Yegezu, Kristin Kollecas, et al.
Journal of Health Economics and Outcomes Research|November 9, 2022
The Economic and Humanistic Burden of Pediatric-Onset Multiple SclerosisNupur Greene, Lita Araujo, Cynthia Campos, et al.
Research in Social & Administrative Pharmacy : RSAP|August 7, 2022
Work productivity loss among adults aged 18-64 years with Multiple Sclerosis in the United States: A propensity score matched studySandipan Bhattacharjee, Zufan Yegezu, Kristin Kollecas, et al.
Journal of Patient-Reported Outcomes|July 4, 2023
Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosisNupur Greene, Stéphane Quéré, Denise P Bury, et al.
Medicine|November 5, 2025
Effectiveness of teriflunomide in patients with relapsing multiple sclerosis who switched from other disease-modifying therapiesRegina Berkovich, Nupur Greene, Sheila R Reddy, et al.
Brain Communications|December 23, 2024
Patterns and predictors of multiple sclerosis phenotype transitionLuigi Pontieri, Nupur Greene, Malthe Faurschou Wandall-Holm, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Managed Care & Specialty Pharmacy|May 13, 2025
Associations between chronic active lesions and clinical outcomes in multiple sclerosis: A systematic literature reviewFrancesca Bagnato, Margaret Mordin, Nupur Greene, et al.
Journal of Comparative Effectiveness Research|November 28, 2022
Health economic outcomes of switching to alemtuzumab from other disease-modifying therapies in people with multiple sclerosis in the USALita Araujo, Srikanth Kyatham, Kristen G Bzdek, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 29, 2022
Medication Adherence and Healthcare Utilization in Relapsing-Remitting Multiple Sclerosis Patients Using TeriflunomideNupur Greene, Keiko Higuchi, Katalin Bognar, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 26, 2023
Assessing the Health Economic Outcomes from Commercially Insured Relapsing Multiple Sclerosis Patients Who Switched from Other Disease-Modifying Therapies to Teriflunomide, in the United StatesLita Araujo, Srikanth Kyatham, Kristen G Bzdek, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 21, 2021
Influence of Comorbidities on Healthcare Expenditures and Perceived Physical and Mental Health Status Among Adults with Multiple Sclerosis: A Propensity Score-Matched US National-Level StudySandipan Bhattacharjee, Zufan Yegezu, Kristin Kollecas, et al.
Journal of Health Economics and Outcomes Research|November 9, 2022
The Economic and Humanistic Burden of Pediatric-Onset Multiple SclerosisNupur Greene, Lita Araujo, Cynthia Campos, et al.
Research in Social & Administrative Pharmacy : RSAP|August 7, 2022
Work productivity loss among adults aged 18-64 years with Multiple Sclerosis in the United States: A propensity score matched studySandipan Bhattacharjee, Zufan Yegezu, Kristin Kollecas, et al.
Journal of Patient-Reported Outcomes|July 4, 2023
Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosisNupur Greene, Stéphane Quéré, Denise P Bury, et al.
Medicine|November 5, 2025
Effectiveness of teriflunomide in patients with relapsing multiple sclerosis who switched from other disease-modifying therapiesRegina Berkovich, Nupur Greene, Sheila R Reddy, et al.
Brain Communications|December 23, 2024
Patterns and predictors of multiple sclerosis phenotype transitionLuigi Pontieri, Nupur Greene, Malthe Faurschou Wandall-Holm, et al.
Pageof 1